<DOC>
	<DOCNO>NCT02594059</DOCNO>
	<brief_summary>The aim study assess peripheral endothelial function adult patient idiopathic pulmonary fibrosis ( IPF ) relationship peripheral endothelial function severity IPF .</brief_summary>
	<brief_title>Assessment Peripheral Endothelial Function Idiopathic Pulmonary Fibrosis</brief_title>
	<detailed_description>The primary criterion peripheral endothelial function assess measure flow-mediated dilation ( reactive hyperemia-peripheral artery tone index ) . The pulmonary function assess measure force expiratory volume one second ( FEV1 ) , force vital capacity ( FVC ) total lung capacity ( TLC ) diffuse capacity lung carbon monoxide ( DLCO ) . The dyspnea assess New York Heart Association ( NYHA ) score . The exercise capacity assess 6-min walk test . Pulmonary arterial pressure record cardiac echography catheterization .</detailed_description>
	<mesh_term>Fibrosis</mesh_term>
	<mesh_term>Pulmonary Fibrosis</mesh_term>
	<mesh_term>Idiopathic Pulmonary Fibrosis</mesh_term>
	<mesh_term>Idiopathic Interstitial Pneumonias</mesh_term>
	<criteria>IPF accord ATS/ERS 2011 's criterion Stable IPF ( reduction FVC DLCO 10 % 15 % respectively ) Patients significant disease IPF . A significant disease define disease , opinion investigator , may influence result trial . Pregnant nursing woman . Nonpulmonary fibrosis treatment pulmonary vasodilator stop 24 hour assessment endothelial function</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>September 2016</verification_date>
	<keyword>endothelial function , idiopathic pulmonary fibrosis</keyword>
</DOC>